Ildong Holdings Co., Ltd.

KSE 000230.KS

Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -12.55 M

Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities is USD -12.55 M for the year ending December 31, 2023, a 51.13% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -25.68 M, a 37.22% change year over year.
Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -40.91 M, a -80.46% change year over year.
Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -22.67 M, a -222.59% change year over year.
Ildong Holdings Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD 18.49 M, a 428.91% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

KSE: 000230.KS

Ildong Holdings Co., Ltd.

CEO	Dae-Chang Park
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	2, Baumoe-ro 27-gil
Employees	78
Sector	Consumer Discretionary
Industries Cosmetics Biotechnology Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Pharmaceuticals

Description

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.

Key trends

Past 5 years